Lazari Capital Management, Inc. Pds Biotechnology Corp Transaction History
Lazari Capital Management, Inc.
- $222 Billion
- Q2 2024
A detailed history of Lazari Capital Management, Inc. transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Lazari Capital Management, Inc. holds 13,000 shares of PDSB stock, worth $48,230. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,000
Previous 11,000
18.18%
Holding current value
$48,230
Previous $43.6 Million
12.56%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding PDSB
# of Institutions
80Shares Held
5.46MCall Options Held
155KPut Options Held
61.7K-
Vanguard Group Inc Valley Forge, PA1.41MShares$5.23 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.81 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny381KShares$1.42 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA378KShares$1.4 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$1.28 Million0.18% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $106M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...